financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lowers Opinion On Shares Of Performance Food Group To Hold From Buy
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lowers Opinion On Shares Of Performance Food Group To Hold From Buy
May 10, 2024 3:20 AM

06:10 AM EDT, 05/10/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target price to $73 from $82 using an EV/EBITDA multiple of 9.6x on FY 25 (Jun.) adj-EBITDA estimate of $1,654M. We lower our FY 24 EPS to $4.22 from $4.43 and FY 25 EPS to $5.05 from $5.20. PFGC posted FQ3 (Mar-Q) adj-EPS of $0.80 (-3.6% Y/Y), $0.04 below consensus. Revenue of $13,858M (+0.6% Y/Y) was $330M below consensus. Adj-EBITDA grew 1.91% Y/Y to $320.7M vs. $326M consensus, with margin widening 3 bps Y/Y to 2.3%. PFGC's total case volume fell 0.2% Y/Y, while organic case growth also decreased 0.6% Y/Y. PFGC faced many challenges, including inclement weather in January, a volatile inflationary environment, and negative calendar shifts. Moreover, PFGC highlighted signs of consumer pressure, which led to negative top-line growth trends at both its Convenience and Vistar segments. However, we were still somewhat encouraged by PFGC's plans to gain market share and control costs, along with the recent rebound in inflation and independent case growth in the Foodservice segment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novartis Ag
Apr 23, 2024
12:45 PM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $3 to $108, implying a 2024 P/E of 15.4x, largely in line with the peer average. Novartis ( NVS ) raised its full-year 2024...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Invesco Ltd.
Apr 23, 2024
10:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We trim our 12-month target by $2 to $16, valuing IVZ shares at 8.6x our 2025 adjusted EPS estimate of $1.85 (cut today by $0.05) and at 10x our 2024...
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Research Alert: CFRA Reiterates Hold Opinion On Shares Of Jetblue Airways Corporation
Apr 23, 2024
11:45 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target of $6.50, down $0.50, reflects a 3.4x multiple of EV to projected '25 EBITDA, a discount to JBLU's historical average. We think a discount is merited due...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Msci Inc.
Apr 23, 2024
11:40 AM EDT, 04/23/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We decrease our target price by $165 to $465, 27.4x our 2025 EPS estimate, a discount to MSCI's ( MSCI ) 10-year forward P/E average of 36.4x given reduced growth...
Copyright 2023-2026 - www.financetom.com All Rights Reserved